Concord Medical Co., Ltd. (TPEX:6518)
48.80
-3.30 (-6.33%)
Apr 20, 2026, 1:18 PM CST
Concord Medical Market Cap
Concord Medical has a market cap or net worth of 1.74 billion as of April 20, 2026. Its market cap has increased by 97.35% in one year.
Market Cap
1.74B
Enterprise Value
1.66B
Revenue
964.35M
Ranking
n/a
PE Ratio
25.92
Stock Price
48.80
Market Cap Chart
Since May 13, 2015, Concord Medical's market cap has increased from 987.00M to 1.74B, an increase of 75.95%. That is a compound annual growth rate of 5.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.74B | 98.85% |
| Dec 31, 2025 | 873.33M | 1.55% |
| Dec 31, 2024 | 860.00M | 0.78% |
| Dec 29, 2023 | 853.33M | 8.47% |
| Dec 30, 2022 | 786.67M | 74.81% |
| Dec 30, 2021 | 450.00M | 28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bionime | 4.64B |
| Maxigen Biotech | 3.76B |
| Nang Kuang Pharmaceutical | 3.60B |
| ICARES Medicus | 3.37B |
| BenQ Medical Technology | 1.84B |
| Crystalvue Medical | 1.78B |
| Chi Sheng Pharma & Biotech | 1.76B |
| Lagis Enterprise | 1.42B |